Fate Therapeutics (FATE) stock forecast for 2022 – 2027

Are you interested in Fate Therapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the FATE stock price in 2022-2027. Is FATE a good long term stock? When should I take profit in Fate Therapeutics stock? Buy or sell stock? Will FATE stock price go up? What are analysts’ forecasts for FATE stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. FATE stock returns are also predicted based on historical data.

According to our research, FATE stock is a awesome long-term investment. FATE share price has been in a bull cycle for the past year. Fate Therapeutics, Inc. stock trend is positive.

Fate Therapeutics company info

Industry Biotechnology
Address 3535 General Atomics Court, San Diego, CA, 92121, United States
Website https://www.fatetherapeutics.com

Forecasting

52 Week High: 66.2964 USD
52 Week Low: 40.2162 USD
1 Year Forecast: 66.2964 USD
5 Year Forecast: 162.506 USD

Agilent Technologies info

Market Cap: 3.73B
52 Week Change: -58.421%
52 Week High: 118.14 USD
52 Week Low: 37.06 USD
Beta: 1.77729
50 Day Moving Average: 52.16
90 Day Moving Average: 51.885
200 Day Moving Average: 64.75
Resistance Level: 46.7
Pivot Point: 40.902
Support Level: 34.4718
Enterprise Value: 4,772,224,512
Forward P/E: -12.90
Forward EPS: -2.84
Profit Margin: 0.00%
Shares Outstanding: 95,492,800
EBITDA: -27.04
Held Percent Institutions: 101.74%
PEG Ratio (5Y): 1.42
Trailing EPS: -2.12

Fate Therapeutics stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Fate Therapeutics Stock Forecast for 2022

March 2022 43.56 43.43 -0.3%
April 2022 42.14 45.54 8.07%
May 2022 45.08 47 4.26%
June 2022 47 50 6.38%
July 2022 49.5 50 1.01%
August 2022 51 49.5 -2.94%
September 2022 49.5 51 3.03%
October 2022 52.02 52.47 0.87%
November 2022 53 54.88 3.55%
December 2022 54.88 61.38 11.84%

Fate Therapeutics Stock Forecast for 2023

January 2023 62 64.35 3.79%
February 2023 65.65 70 6.63%
March 2023 70 67.62 -3.4%
April 2023 70.38 70.29 -0.13%
May 2023 72.42 73.44 1.41%
June 2023 71.28 74.25 4.17%
July 2023 76 77.52 2%
August 2023 74.48 76.76 3.06%
September 2023 75 78.54 4.72%
October 2023 75.46 80.58 6.79%
November 2023 77.42 79.38 2.53%
December 2023 81.81 87.12 6.49%

Fate Therapeutics Stock Forecast for 2024

January 2024 89.76 90.9 1.27%
February 2024 89.1 95 6.62%
March 2024 95 94.94 -0.06%
April 2024 94 96.03 2.16%
May 2024 95.06 97.97 3.06%
June 2024 96.04 103.02 7.27%
July 2024 102.01 100.98 -1.01%
August 2024 99.96 103.02 3.06%
September 2024 102.01 103.02 0.99%
October 2024 104.04 106.08 1.96%
November 2024 105.04 106 0.91%
December 2024 108.07 114.13 5.61%

Fate Therapeutics Stock Forecast for 2025

January 2025 111.87 113.85 1.77%
February 2025 117 120 2.56%
March 2025 118.8 116.62 -1.84%
April 2025 117.81 120.78 2.52%
May 2025 120.78 119.56 -1.01%
June 2025 120.54 124.74 3.48%
July 2025 127 129.54 2%
August 2025 124.46 126 1.24%
September 2025 123.48 126.72 2.62%
October 2025 125.44 126.42 0.78%
November 2025 130.29 133.62 2.56%
December 2025 133.32 137.61 3.22%

Fate Therapeutics Stock Forecast for 2026

January 2026 141.78 140 -1.26%
February 2026 139.59 147.46 5.64%
March 2026 147.46 145 -1.67%
April 2026 147.9 148.47 0.39%
May 2026 144.06 146.52 1.71%
June 2026 149.48 150.48 0.67%
July 2026 152 155.04 2%
August 2026 152 152.51 0.34%
September 2026 153.52 153 -0.34%
October 2026 156.06 153.45 -1.67%
November 2026 153.45 155.43 1.29%
December 2026 155.43 164 5.51%

Fate Therapeutics Stock Forecast for 2027

January 2027 162.36 168.3 3.66%